|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-22
|
|
pubmed:abstractText |
Postoperative pancreatic fistula (postoperative pancreatic fistula [POPF]) is the most common complication after pancreaticoduodenectomy. Despite some studies showing little effect of octreotide in unselected patients, we hypothesized that in high-risk patients depot octreotide may reduce the risk of POPF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1879-1883
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
201
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
481-5
|
|
pubmed:meshHeading |
pubmed-meshheading:21421102-Delayed-Action Preparations,
pubmed-meshheading:21421102-Gastrointestinal Agents,
pubmed-meshheading:21421102-Humans,
pubmed-meshheading:21421102-Octreotide,
pubmed-meshheading:21421102-Pancreatic Fistula,
pubmed-meshheading:21421102-Pancreaticoduodenectomy,
pubmed-meshheading:21421102-Premedication,
pubmed-meshheading:21421102-Prospective Studies,
pubmed-meshheading:21421102-Retrospective Studies,
pubmed-meshheading:21421102-Risk Assessment,
pubmed-meshheading:21421102-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
|
|
pubmed:affiliation |
Department of Surgery, Georgetown University, Washington, DC 20007, USA.
|
|
pubmed:publicationType |
Journal Article
|
